Validation of an Allergic Rhinitis Control Test in Children
University Hospital, Montpellier
135 participants
May 4, 2017
INTERVENTIONAL
Conditions
Summary
Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in teenagers or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitis (ARCT) in patients from 12 years of age. We propose to adapt ARCT adult to pediatric population from 5 to 11 years old.
Eligibility
Inclusion Criteria2
- Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
- Parents formulated their study participation agreement by signing the consent form.
Exclusion Criteria1
- Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
self questionnaire for allergic rhinitis control
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03075917